$982,669,952 in Total Settlement Funds Available. See if you qualify!Find Out More

Avalanche Biotechnologies, Inc. (n/k/a Adverum Biotechnologies, Inc.) (California Superior Court) Settlement
(AAVL)
Settlement

Claim Deadline: December 27, 2017

Settlement Fund: $13,000,000

Settlement Class

ALL PERSONS THAT PURCHASED OR OTHERWISE ACQUIRED AVALANCHE BIOTECHNOLOGIES, INC.  COMMON STOCK BETWEEN JULY 30, 2014 AND JUNE 15, 2015, INCLUDING THOSE PERSONS THAT PURCHASED OR OTHERWISE ACQUIRED THE COMPANY’S COMMON STOCK PURSUANT OR TRACEABLE TO THE COMPANY’S REGISTRATION STATEMENT AND PROSPECTUS FOR THE COMPANY’S IPO AND THOSE PERSONS THAT PURCHASED OR OTHERWISE ACQUIRED THE COMPANY’S COMMON STOCK PURSUANT OR TRACEABLE TO THE COMPANY’S REGISTRATION STATEMENT AND PROSPECTUS FOR THE COMPANY’S SPO.

Important Documents

Settlement Status

Disbursed

Class Period

July 30, 2014 - June 15, 2015

Settlement Hearing Date

November 27, 2017

Opt-Out Deadline

November 27, 2017

Settlement Website

N/A

Claims Admin

Gilardi & Co. LLC
Avalanche Securities Litigation Settlement Claims Administrator c/o Gilardi & Co. LLC
P.O. Box 404025
Louisville, KY 40233-4025 
+1 877-764-5656
info@AvalancheSecuritiesLitigationSettlement.com

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.